Animal experiments showed that FAM168A interference can prolong the survival duration and reduce the tumorigenesis rate in K562/siFAM168A mice, suggesting that FAM168A may promote the growth and metastasis of CML cells. The gene discussed is FAM168A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.